Home Investors News Press Releases 2004

If you would like to be alerted when a press release is added to this site, please register with the Alerting Service.

Select a month	AllJanuary February March April May June July August September October November December
Select a year	All2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997
Search for:

12/07/2004	Seliciclib (CYC202) Shown To Kill Multiple Myeloma Cells
12/04/2004	Cyclacel Announces Discovery Of Aurora Kinase Inhibitors
11/08/2004	Science Selects Cyclacel Work As Editor's Choice
11/08/2004	Beneficial Effects Of Seliciclib (CYC202) Reported In Models Of Kidney Disease
09/07/2004	Cyclacel Initiates Patient Enrollment In Third Phase I Clinical Trial Of CYC682
07/26/2004	Cyclacel Announces Postponement Of Initial Public Offering
02/18/2004	Cyclacel To Present At BIO CEO & Investor Conference
01/29/2004	Cyclacel Completes $39 Million Private Placement

  Go to top      Print page